Drug recall D-1125-2019
Product
Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-536-37.
Reason for recall
Presence of Particulate Matter.
Lots and codes
Lots #: GH80216 Exp 1/2020; GH80322, GH80323 Exp 2/2020; GH90072 Exp 12/2020.
Recall details
- Recalling firm
- InvaGen Pharmaceuticals, Inc., Central Islip, NY
- Quantity
- 75968 vials
- Distribution
- Nationwide in the U.S.A.
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 22, 2019
- Terminated
- August 16, 2022
Related products
- Testosterone Cypionate – drug information
- NDC 69097-537 Testosterone Cypionate · Testosterone Cypionate 200 mg/mL · Cipla USA Inc.
- NDC 69097-536 Testosterone Cypionate · Testosterone Cypionate 100 mg/mL · Cipla USA Inc.